Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.
about
Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytesSynthetic muscle promoters: activities exceeding naturally occurring regulatory sequences.Reverse micelle-mediated synthesis of calcium phosphate nanocarriers for controlled release of bovine serum albuminGene therapy for kidney disease.Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy.Tie2-dependent neovascularization of the ischemic hindlimb is mediated by angiopoietin-2.Block copolymeric biotransport carriers as versatile vehicles for drug delivery.Chronic restraint stress upregulates erythropoiesis through glucocorticoid stimulation.Non-viral gene delivery in skeletal muscle: a protein factory.High-efficiency gene transfer into skeletal muscle mediated by electric pulses.Development of optimized vectors for gene therapy.DNA vaccines coding for heat-shock proteins (HSPs): tools for the activation of HSP-specific regulatory T cells.Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.Progress toward a nonviral gene therapy protocol for the treatment of anemia.Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporationComparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.Plasmid DNA encoding transforming growth factor-beta1 suppresses chronic disease in a streptococcal cell wall-induced arthritis model.Emerging technologies in the delivery of erythropoietin for therapeutics.Enhanced muscle growth by plasmid-mediated delivery of myostatin propeptide.A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.Non-replicating Epstein-Barr virus-based plasmids extend gene expression and can improve gene therapy in vivo.Sodium phosphate enhances plasmid DNA expression in vivo.Fabrication and characterization of DNA-loaded zein nanospheres.Optimization of human erythropoietin secretion from MLV-infected human primary fibroblasts used for encapsulated cell therapy.Increased level and duration of expression in muscle by co-expression of a transactivator using plasmid systems.Human insulin production and amelioration of diabetes in mice by electrotransfer-enhanced plasmid DNA gene transfer to the skeletal muscle.Luteinizing hormone plasmid therapy results in long-lasting high circulating Lh and increased sperm production in European sea bass (Dicentrarchus labrax).Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin.A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice.Plasmid DNA electrotransfer: a new non viral method for gene therapy in oncology.Correction of anemia in uremic rats by intramuscular injection of lentivirus carrying an erythropoietin gene.Activity and safety of DNA plasmids encoding IL-4 and IFN gamma.Electropermeabilization of skeletal muscle enhances gene transfer in vivo.A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle.Ovine adenovirus vectors mediate efficient gene transfer to skeletal muscle.Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA.Long-term production of erythropoietin after electroporation-mediated transfer of plasmid DNA into the muscles of normal and uremic rats.
P2860
Q24682549-4EE0EB14-0A94-40EC-B6BF-98B89C8707A2Q30657785-389C7168-FC75-4921-8DB7-BAE6777B04AEQ33671540-B8117952-68A3-4BD8-8802-5FBA6BA1F1D1Q34074844-1D3963E2-8A03-49A9-823E-D80B51BB9FB7Q34106220-536CB51F-831C-4EF8-935A-88B00FDB9004Q34437834-C9FD3604-A4F9-4A7A-9A1B-7A31CE80BC85Q34451869-A35F1730-534F-46A5-8FC6-44A2BDFB2D25Q35035807-3DC51EE6-5BF2-4A09-9C4B-5106ABFF83A5Q35061706-DE222555-F125-41B2-85E3-26CFAB8A5CC8Q35123357-7FEBF8AD-D4BB-4BDF-A53F-0E58FF2BE422Q35965985-13D5D021-DE0D-4CEC-829E-7F95BF908A2BQ36150452-EFA94A4E-6138-44D3-AD91-4CB4E5CB6007Q36159178-755C4259-D0D7-4793-BD7A-EC72516EFF02Q36431079-83C22516-01F1-44D4-B317-20AFE98C7E83Q36499510-B90E1154-AA1E-494C-8739-F933E690814FQ37210391-B878A710-1249-40A7-A56C-8F3224BF254DQ37372668-5A551880-E55E-45A6-ABB1-FBFC8D30CCA5Q37379766-410D1BF3-DB71-4B0E-8708-1E37D8EC52FCQ37383110-F5936B3B-85D3-47C3-A3AD-8F725A45BCC4Q37646523-B34AD94A-5667-4013-B883-1851E58CB788Q39673516-A98E0B16-D4BF-49C3-B8BC-6ED32E9773A5Q40705863-B6E33422-858B-4B43-A988-011212F7EEE6Q40810334-D57E11C9-957E-440B-9671-E6AE6EEBD406Q41741739-C52E593A-DE1F-4F71-B5AE-DF8AC9A43B42Q41751620-01BF5301-8478-4293-806C-86B56B35CF80Q42415385-B262EBB2-D202-4EE6-98BD-2BCDADF62AEAQ42439025-8FA83B61-EDBE-4CA0-B7CD-A0976FB04595Q44061754-1288C465-13FC-4315-9487-D2C9DFD027A7Q44178360-5893151B-CAE3-4026-8738-82B4EDFB988CQ45125275-D8D99EAC-948F-4864-8789-1C5E9D46DB67Q45855299-2DE29D14-8AB7-40D3-BC3C-8CB6EE34ECA3Q45859123-2FF00ED9-D37F-4107-9BA4-3EE20B77FF6FQ45859156-2AAFF412-C5E7-47D8-ADE9-2835642F3F8BQ45859537-A7FE7F68-1DD8-48A2-B74E-B5AA8AEDB58CQ45861110-D8648ACE-EE26-4232-9D19-BB5EE99FD5BCQ45862087-D0A42857-020C-40C4-AC42-1E473799A7F1Q45868505-C62CA984-7BA7-4C04-8BAB-364E91241743Q45871061-34B11EF7-E66B-48CC-A37A-1741DA8A58FCQ45872976-0E52977A-9D2B-45AB-A239-5CFCCF12CA89Q45876557-5447907C-9E4D-449A-BC01-2D71FE7FD755
P2860
Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@en
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@nl
type
label
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@en
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@nl
prefLabel
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@en
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@nl
P2093
P2860
P356
P1476
Long-term expression of erythr ...... ction of a plasmid DNA vector.
@en
P2093
E C Svensson
E Goldwasser
J M Leiden
M Margalith
P M Hobart
S K Tripathy
P2860
P304
10876-10880
P356
10.1073/PNAS.93.20.10876
P407
P577
1996-10-01T00:00:00Z